keyword
https://read.qxmd.com/read/38019131/sertraline-with-desvenlafaxine-and-sertraline-with-mirtazapine-as-treatment-initiation-in-mdd-patients-with-moderate-to-severe-depression-and-effect-on-inflammatory-markers
#61
JOURNAL ARTICLE
Norman Arockiaraj, Rachna Gupta, Rafat Ahmad, Sumita Halder, M S Bhatia
BACKGROUND: This study evaluated the effect of sertraline with desvenlafaxine and sertraline with mirtazapine on HAM-D score and inflammatory markers (IL-6 and TNF-α levels) in major depressive disorder. METHODS: Patients (18-60 years) with MDD diagnosed by DSM-V criteria and HAM-D score 18 or more were included ( n  = 60). Group A patients ( n  = 30) received sertraline 50 mg/day and desvenlafaxine 50 mg/day...
November 29, 2023: International Journal of Psychiatry in Clinical Practice
https://read.qxmd.com/read/38015216/obesity-management-in-adults-a-review
#62
REVIEW
Arielle Elmaleh-Sachs, Jessica L Schwartz, Carolyn T Bramante, Jacinda M Nicklas, Kimberly A Gudzune, Melanie Jay
IMPORTANCE: Obesity affects approximately 42% of US adults and is associated with increased rates of type 2 diabetes, hypertension, cardiovascular disease, sleep disorders, osteoarthritis, and premature death. OBSERVATIONS: A body mass index (BMI) of 25 or greater is commonly used to define overweight, and a BMI of 30 or greater to define obesity, with lower thresholds for Asian populations (BMI ≥25-27.5), although use of BMI alone is not recommended to determine individual risk...
November 28, 2023: JAMA
https://read.qxmd.com/read/38001492/discontinuation-of-antidepressant-treatment-a-retrospective-cohort-study-on-more-than-20-000-participants
#63
JOURNAL ARTICLE
Luis M Garcia-Marin, Aoibhe Mulcahy, Enda M Byrne, Sarah E Medland, Naomi R Wray, Freddy Chafota, Penelope A Lind, Nicholas G Martin, Ian B Hickie, Miguel E Rentería, Adrian I Campos
BACKGROUND: Factors influencing antidepressant treatment discontinuation are poorly understood. In the present study, we aimed to estimate the prevalence of antidepressant treatment discontinuation and identify demographic characteristics, psychiatric comorbidities, and specific side effects associated with treatment discontinuation. METHODS: We leveraged data from the Australian Genetics of Depression Study (AGDS; N = 20,941) to perform a retrospective cohort study on antidepressant treatment discontinuation...
November 24, 2023: Annals of General Psychiatry
https://read.qxmd.com/read/37992105/atypical-neuroleptic-malignant-syndrome-associated-with-mirtazapine-use
#64
Talha Ağaç, Hasan Gökçay, Mustafa Solmaz
No abstract text is available yet for this article.
2023: Psychiatria Danubina
https://read.qxmd.com/read/37987716/real-world-assessment-of-treatment-inertia-in-the-management-of-patients-treated-for-major-depressive-disorder-in-the-usa
#65
JOURNAL ARTICLE
John J Sheehan, Chris LaVallee, Keshia Maughn, Santosh Balakrishnan, Jacqueline A Pesa, Kruti Joshi, Craig Nelson
Aim: Major depressive disorder (MDD) is a debilitating illness in which depressive symptoms may persist after treatment. Treatment inertia is the continued use of the same pharmacotherapy regimen when treatment goals are not met. This study assessed the frequency of treatment inertia among adult patients with MDD treated in a real-world setting. Patients & methods: This was a retrospective, observational study of patients with MDD identified in the Decision Resources Group Real World Evidence US Data Repository from January 2014 to June 2018...
November 21, 2023: Journal of Comparative Effectiveness Research
https://read.qxmd.com/read/37986777/structural-insights-into-the-unexpected-agonism-of-tetracyclic-antidepressants-at-serotonin-receptors-5-ht-1e-r-and-5-ht-1f-r
#66
Gregory Zilberg, Alexandra K Parpounas, Audrey L Warren, Bianca Fiorillo, Davide Provasi, Marta Filizola, Daniel Wacker
Serotonin (5-hydroxytryptamine, 5-HT) acts via 13 different receptors in humans. Of these receptor subtypes, all but 5-HT 1e R have confirmed roles in native tissue and are validated drug targets. Despite 5-HT 1e R's therapeutic potential and plausible druggability, the mechanisms of its activation remain elusive. To illuminate 5-HT 1e R's pharmacology in relation to the highly homologous 5-HT 1F R, we screened a library of aminergic receptor ligands at both receptors and observe 5-HT 1e/1F R agonism by multicyclic drugs described as pan-antagonists at 5-HT receptors...
October 7, 2023: bioRxiv
https://read.qxmd.com/read/37970263/the-interface-between-depression-and-alzheimer-s-disease-a-comprehensive-approach
#67
JOURNAL ARTICLE
Pedro J Modrego, Leyre D de Cerio, Antonio Lobo
Depression and Alzheimer's disease (AD) are frequent interacting diseases in the elderly with a negative impact on the quality of life of patients and caregivers. Late-life depression may be regarded either as an early symptom of AD or a risk factor for AD, depending on the context. This review was focused on the latest developments in the fields of the neurobiological basis and treatment of depression in AD. We found that some plausible hypotheses are emerging to correlate with depression in AD, such as neuroinflammation and dysimmune regulation...
2023: Annals of Indian Academy of Neurology
https://read.qxmd.com/read/37965066/a-review-on-linking-stress-depression-and-insulin-resistance-via-low-grade-chronic-inflammation
#68
REVIEW
Seema Mehdi, Shahid Ud Din Wani, K L Krishna, Nabeel Kinattingal, Tamsheel Fatima Roohi
Stress is a disturbance in homeostasis caused by psychological, physiological, or environmental factors. Prolonged reactions to chronic stress can be detrimental, resulting in various metabolic abnormalities, referred to as metabolic syndrome (MS). There is a reciprocal increased risk between MS and major depressive disorder. Recent studies established an association between inflammation and insulin signaling in type 2 diabetes mellitus with depression. In the present review, we discuss chronic low-grade inflammation, pathways of insulin resistance, and brain glucose metabolism in the context of neuroinflammation and depression...
December 2023: Biochemistry and Biophysics Reports
https://read.qxmd.com/read/37944561/prevalence-of-covid-19-and-psychotropic-drug-treatment-in-psychiatric-in-patients-in-germany-in-2020-results-from-a-nationwide-pilot-survey
#69
JOURNAL ARTICLE
Juliane K Mueller, Kira F Ahrens, Michael Bauer, Bernhard T Baune, Stefan Borgwardt, Jürgen Deckert, Katharina Domschke, Regina Ellwanger, Andreas Fallgatter, Thomas Frodl, Jürgen Gallinat, René Gottschalk, Hans J Grabe, Alkomiet Hasan, Sabine C Herpertz, Rene Hurlemann, Frank Jessen, Joseph Kambeitz, Tilo Kircher, Johannes Kornhuber, Klaus Lieb, Andreas Meyer-Lindenberg, Rainer Rupprecht, Norbert Scherbaum, Christiane Schlang, Anja Schneider, Georg Schomerus, Andreas Thoma, Stefan Unterecker, Martin Walter, Henrik Walter, Andreas Reif, Christine Reif-Leonhard
INTRODUCTION: In patients with a pre-existing mental disorder, an increased risk for a first manifestation of a psychiatric disorder in COVID-19 patients, a more severe course of COVID-19 and an increased mortality have been described. Conversely, observations of lower COVID-19 incidences in psychiatric in-patients suggested protective effects of psychiatric treatment and/or psychotropic drugs against COVID-19. METHODS: A retrospective multi-center study was conducted in 24 German psychiatric university hospitals...
November 2023: Pharmacopsychiatry
https://read.qxmd.com/read/37943296/pharmacological-update-of-mirtazapine-a-narrative-literature-review
#70
REVIEW
Emad H M Hassanein, Hanan S Althagafy, Mohammad A Baraka, Esraa K Abd-Alhameed, Islam M Ibrahim
Mirtazapine (MTZ) is an antidepressant drug with an exceptional pharmacological profile. It also has an excellent safety and tolerability profile. The present review provides a pharmacological update on MTZ and summarizes the research findings of MTZ's effects on different diseases. MTZ is hypothesized to have antidepressant effects because of the synergy between noradrenergic and serotonergic actions and is effective in treating major depressive disorder and depression associated with epilepsy, Alzheimer's disease, stroke, cardiovascular disease, and respiratory disease...
November 9, 2023: Naunyn-Schmiedeberg's Archives of Pharmacology
https://read.qxmd.com/read/37941526/peripheral-edema-associated-with-antidepressant-use-systematic-review-of-case-reports
#71
REVIEW
Jithin T Joseph, Rashmi Vishwanath, Samir Kumar Praharaj
BACKGROUND: Oedema associated with psychotropics can impose a considerable burden, leading to increased morbidity and cost. Peripheral oedema is sometimes related to the use of antidepressants, which are among the most prescribed psychotropic medications. We reviewed the reported cases of antidepressant-associated oedema to understand the risk factors, aetiology and outcome. METHODS: We searched the Medline, Web of Science and Embase databases to identify reported cases of peripheral oedema associated with antidepressant use...
November 2023: Human Psychopharmacology
https://read.qxmd.com/read/37941108/pharmacobezoar-related-fatalities-a-case-report-and-a-review-of-the-literature
#72
JOURNAL ARTICLE
Guillaume Drevin, Stéphane Malbranque, Nathalie Jousset, Séverine Férec, Donca Zabet, Antoine Baudriller, Marie Briet, Chadi Abbara
Pharmacobezoars develop after an acute overdose or during routine drug administration. Here, the authors present a case of fatal multidrug overdose involving a 62-year-old woman. Her usual treatment included tramadol extended-release, citalopram, and mirtazapine. Furthermore, she self-medicated and misused her husband's medications. The autopsy revealed the presence of a voluminous medication bezoar in the stomach. No mechanical complication was noted. Toxicologic analyses were performed using gas chromatography with flame ionization detection, liquid chromatography with diode array detection, gas chromatography with mass spectrometry detection, and liquid chromatography coupled to tandem mass spectrometry...
November 8, 2023: Therapeutic Drug Monitoring
https://read.qxmd.com/read/37929672/a-pragmatic-multicentre-double-blind-placebo-controlled-randomised-trial-to-assess-the-safety-clinical-and-cost-effectiveness-of-mirtazapine-and-carbamazepine-in-people-with-alzheimer-s-disease-and-agitated-behaviours-the-hta-symbad-trial
#73
RANDOMIZED CONTROLLED TRIAL
Sube Banerjee, Nicolas Farina, Catherine Henderson, Juliet High, Susan Stirling, Lee Shepstone, Julia Fountain, Clive Ballard, Peter Bentham, Alistair Burns, Chris Fox, Paul Francis, Robert Howard, Martin Knapp, Iracema Leroi, Gill Livingston, Ramin Nilforooshan, Shirley Nurock, John O'Brien, Annabel Price, Alan J Thomas, Ann Marie Swart, Tanya Telling, Naji Tabet
BACKGROUND: Agitation is common and impacts negatively on people with dementia and carers. Non-drug patient-centred care is first-line treatment, but we need other treatment when this fails. Current evidence is sparse on safer and effective alternatives to antipsychotics. OBJECTIVES: To assess clinical and cost-effectiveness and safety of mirtazapine and carbamazepine in treating agitation in dementia. DESIGN: Pragmatic, phase III, multicentre, double-blind, superiority, randomised, placebo-controlled trial of the clinical effectiveness of mirtazapine over 12 weeks (carbamazepine arm discontinued)...
October 2023: Health Technology Assessment: HTA
https://read.qxmd.com/read/37905412/gabapentin-and-oral-antidepressants-for-chronic-pruritus-a-prospective-cohort-study-evaluating-efficacy-and-side-effects-in-daily-dermatological-practice
#74
JOURNAL ARTICLE
T A Kouwenhoven, P C M van de Kerkhof, M Kamsteeg
BACKGROUND: Chronic pruritus is frequently seen in daily dermatological practice and is associated with marked impact on quality of life. Research on the use of gabapentin and oral antidepressants in daily dermatological practice is scarce. OBJECTIVE: To evaluate the efficacy and safety of gabapentin and oral antidepressants in patients with chronic pruritus in daily clinical practice. METHODS: A prospective observational single-center cohort study was conducted including adult patients with chronic pruritus and an indication for systemic treatment between June 2016 and May 2019...
December 2023: Journal of Dermatological Treatment
https://read.qxmd.com/read/37849303/real-world-evidence-on-clinical-outcomes-of-commonly-used-antidepressants-in-older-adults-initiating-antidepressants-for-depression-a-nationwide-cohort-study-in-denmark
#75
JOURNAL ARTICLE
Kazi Ishtiak-Ahmed, Katherine L Musliner, Kaj Sparle Christensen, Erik Lykke Mortensen, Andrew A Nierenberg, Christiane Gasse
OBJECTIVE: The authors investigated the clinical outcomes of commonly used antidepressants among older adults who initiated first-time antidepressants for depression by analyzing the 1-year risk of selected clinically relevant outcomes. METHODS: This cohort study used nationwide Danish registry data and included all older adults who redeemed a first-time (since 1995) antidepressant prescription with an indication of depression between 2006 and 2017. Only the 10 most frequently redeemed antidepressants were included in the analyses...
January 1, 2024: American Journal of Psychiatry
https://read.qxmd.com/read/37829299/harder-better-faster-stronger-retrospective-chart-review-of-adverse-events-of-interactions-between-adaptogens-and-antidepressant-drugs
#76
JOURNAL ARTICLE
Marcin Siwek, Jarosław Woroń, Anna Wrzosek, Jarosław Gupało, Adrian Andrzej Chrobak
Aim: We aimed to systematically evaluate the prevalence and clinical characteristics of adverse events associated with the adaptogens and antidepressant drug interactions in a retrospective chart review. Methodology: A total of 1,816 reports of adverse events were evaluated. Cases were included in the analysis if the pharmacoepidemiological analysis showed the presence of a high probability of a causal relationship between an adaptogen and antidepressant interaction and the occurrence of adverse events. The following data were extracted from the reports: age, sex, antidepressant, plant products containing adaptogens, other concomitant medications, and clinical consequences of the interactions and their possible mechanisms...
2023: Frontiers in Pharmacology
https://read.qxmd.com/read/37828025/adra2a-and-irx1-are-putative-risk-genes-for-raynaud-s-phenomenon
#77
JOURNAL ARTICLE
Sylvia Hartmann, Summaira Yasmeen, Benjamin M Jacobs, Spiros Denaxas, Munir Pirmohamed, Eric R Gamazon, Mark J Caulfield, Harry Hemingway, Maik Pietzner, Claudia Langenberg
Raynaud's phenomenon (RP) is a common vasospastic disorder that causes severe pain and ulcers, but despite its high reported heritability, no causal genes have been robustly identified. We conducted a genome-wide association study including 5,147 RP cases and 439,294 controls, based on diagnoses from electronic health records, and identified three unreported genomic regions associated with the risk of RP (p < 5 × 10-8 ). We prioritized ADRA2A (rs7090046, odds ratio (OR) per allele: 1...
October 12, 2023: Nature Communications
https://read.qxmd.com/read/37801864/associations-between-insomnia-medications-and-risk-of-death-by-suicide
#78
JOURNAL ARTICLE
Jill E Lavigne, Kwan Hur, Jason B Gibbons, Wilfred R Pigeon
PURPOSE: Insomnia is a modifiable risk factor for suicide often treated with medications. However, little is known about the associations between insomnia medications and risk of death by suicide. The purpose of this study is to model the comparative risk of suicide by each insomnia medication compared to zolpidem, a sedative-hypnotic approved for insomnia. METHODS: First prescription fills of medications commonly used to treat insomnia were identified in electronic medical records...
November 2023: Sleep Medicine
https://read.qxmd.com/read/37792759/antidepressant-medications-are-associated-with-increased-risk-of-hospital-acquired-clostridioides-difficile-infection-a-population-based-study
#79
JOURNAL ARTICLE
Antoine Boustany, Somtochukwu Onwuzo, Hadi Khaled Abou Zeid, Ashraf Almomani, Imad Asaad
•The rate and severity of Clostridioides difficile infection (CDI) has increased throughout North America, the United Kingdom, and Europe. •Scattered evidence about the association of CDI with antidepressant medications use exists in the literature so far. What are the new findings: •The risk of Clostridioides difficile infection is higher in patients who are on mirtazapine, nortriptyline, or trazodone. •The prevalence rate of Clostridioides difficile infection in patients who were using antidepressant medications and the ones who did not, increased with age...
2023: Arquivos de Gastroenterologia
https://read.qxmd.com/read/37758013/differential-targeting-of-lysophosphatidic-acid-lpa-1-lpa-2-and-lpa-3-receptor-signalling-by-tricyclic-and-tetracyclic-antidepressants
#80
JOURNAL ARTICLE
Maria C Olianas, Simona Dedoni, Pierluigi Onali
We previously reported that in different cell types antidepressant drugs activate lysophosphatidic acid (LPA) LPA1 receptor to induce proliferative and prosurvival responses. Here, we further characterize this unique action of antidepressants by examining their effects on two additional LPA receptor family members, LPA2 and LPA3 . Human LPA1-3 receptors were stably expressed in HEK-293 cells (HEK-LPA1 , -LPA2 and -LPA3 cells) and their functional activity was determined by Western blot and immunofluorescence...
September 25, 2023: European Journal of Pharmacology
keyword
keyword
67229
4
5
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.